JLK, Inc. (322510.KQ) — Stock Score Summary

JLK, Inc. (322510.KQ) has a MoatMap StockRank of 3/100 based on Quality (15/100), Value (38/100), and Momentum (23/100) factor scores. The current signal is STRONG SELL.

JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions.

Key Financial Metrics

Price$2.80
Market Cap$73M
Price/Book2.59
Return on Equity-33.5%
Return on Invested Capital-24.1%
Debt/Equity80.17
Gross Margin98.0%
Operating Margin-819.8%
Revenue Growth-15.1%
Free Cash Flow$-5K

JLK, Inc. operates in the Conglomerates industry, part of the Industrials sector (South Korea).

Frequently Asked Questions

What is JLK, Inc.’s (322510.KQ) StockRank?
MoatMap’s StockRank for JLK, Inc. (322510.KQ) is 3/100, with a Strong Sell signal. It is a composite of Quality (15), Value (38), and Momentum (23) factor ranks across MoatMap’s 19,000+ stock universe.
Does JLK, Inc. have an economic moat?
JLK, Inc. (322510.KQ) has a Quality factor score of 15/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is JLK, Inc. a buy, hold, or sell?
MoatMap’s current signal for JLK, Inc. (322510.KQ) is Strong Sell, based on a StockRank of 3/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is JLK, Inc. in?
JLK, Inc. (322510.KQ) operates in the Industrials sector, specifically the Conglomerates industry (South Korea).